DarioHealth Corp. has announced amendments to its Series C, C-1, and C-2 Preferred Stock bylaws. The changes extend the mandatory conversion period from 15 to 24 months from the original issue date. Additionally, a 15% dividend in Common Stock will be issued for each full quarter anniversary of holding the preferred stock following the amendments. No additional securities were issued or sold as a result of these changes.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.